Inventiva (IVEVF) Current Deferred Revenue (2018 - 2025)
Inventiva (IVEVF) posted Current Deferred Revenue of $1.2 million for Q2 2025, up 36584.79% on a QoQ basis from $3230.7 in Q2 2024, and up 36584.79% year-over-year from N/an in Q2 2024.
Analysis
Inventiva (IVEVF) Current Deferred Revenue (2018 - 2025) Analysis & Trends
Inventiva has reported Current Deferred Revenue for 5 years, with the latest figure at $1.2 million in Q2 2025.
- On a quarterly basis, Current Deferred Revenue rose 36584.79% year-over-year to $1.2 million in Q2 2025; TTM through Jun 2025 was $1.2 million, a 36584.79% increase from a year earlier, with the FY2023 full-year figure at $6455.6, down 100.0% from the prior year.
- Current Deferred Revenue was $1.2 million for Q2 2025 at Inventiva, up from $3230.7 in the prior quarter.
- The five-year high for Current Deferred Revenue was $56.1 billion in Q4 2022, with the low at $3230.7 in Q2 2024.
- Average Current Deferred Revenue over 4 years is $9.4 billion, with a median of $480774.6 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue plunged 100.0% in 2023, then jumped 36584.79% in 2025.
- Over 4 years, Current Deferred Revenue stood at $56.1 billion in 2022, then sank by 100.0% to $6455.6 in 2023, then slumped by 49.96% to $3230.7 in 2024, then surged by 36584.79% to $1.2 million in 2025.
- The last three Current Deferred Revenue figures came in at $1.2 million (Q2 2025), $3230.7 (Q2 2024), and $6455.6 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 1.19 Mn |
| Jun 30, 2024 | 3,230.66 |
| Dec 31, 2023 | 6,455.64 |
| Jun 30, 2023 | 6,533.55 |
| Dec 31, 2022 | 56.11 Bn |
| Jun 30, 2022 | 955,015.74 |
| Dec 31, 2018 | 625,485.24 |